Welcome international healthcare professionals

This site is no longer supported and will not be updated with new content. You are welcome to browse and download all content already included in the site. Please note you will have to register your email address to access the site.

You are here

New drug for peripheral and cutaneous T-cell lymphomas

Sharan Prakash Sharma

The Lancet Oncology, Volume 15, Issue 6, May 2014, Pages e200

 

Mogamulizumab, a CC chemokine receptor (CCR4) antibody, could provide a novel treatment option for patients with relapsed peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) according to a new study .


E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre


Search this site

Search form